Iovance Biotherapeutics: Q3 Earnings Snapshot
In this article:
SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $113.8 million in its third quarter.
The San Carlos, California-based company said it had a loss of 46 cents per share.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of 46 cents per share.
The biotechnology company posted revenue of $469,000 in the period, missing Street forecasts. Six analysts surveyed by Zacks expected $3.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA
